Arkema (OTCMKTS:ARKAY) Sees Unusually-High Trading Volume – Should You Buy?

Arkema SA (OTCMKTS:ARKAY) saw an uptick in trading volume on Tuesday . 4,372 shares changed hands during trading, a decline of 26% from the previous session’s volume of 5,905 shares.The stock last traded at $67.83 and had previously closed at $66.5847.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ARKAY. The Goldman Sachs Group raised Arkema from a “hold” rating to a “buy” rating in a research report on Tuesday, February 10th. Kepler Capital Markets lowered Arkema from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 27th. Finally, Zacks Research downgraded Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 6th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

Arkema Price Performance

The company has a market cap of $5.09 billion, a PE ratio of 76.89, a PEG ratio of 1.63 and a beta of 0.87. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.13 and a quick ratio of 1.63. The stock’s 50-day moving average is $66.10 and its 200 day moving average is $62.84.

About Arkema

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.